Arcturus Therapeutics
Clinical stage vaccine developer
Based in CA
AI Overview
With $210K in lobbying spend across 5 quarterly filings, Arcturus Therapeutics is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2020 to 2021.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $170K |
| 2021 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Arcturus Therapeutics disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, Budget/Appropriations
Issues related to Operation WARP Speed.
Issues related to Operation WARP Speed, FDA, vaccine development and distribution.
Issues related to H.R. 925 - The Heroes Act.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.